Medrobotics® Corporation Flex® Robotic System Receives Best New Product Award at 2017 Edison Awards

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Innovative Advances in Surgical Technology Recognized

Medrobotics Corp., a medical products company, announced today that its Flex® Robotic System received a Best New Product Award at the 2017 Edison Awards™. The Company’s rich history of innovation was recognized with a Bronze Award in the Surgical Tools category.

The Edison Awards™ is an annual competition honoring excellence in new product and service development, marketing, human-centered design, and innovation. The competition is open to progressive organizations across the globe. Award winners represent “game changing” products and services, as well as excellence and leadership in innovation. This year, more than 3,000 companies submitted applications. The winners were chosen as the “best of the best” by a panel comprised of individuals selected from the world’s top senior business executives, academics, and innovation professionals.

“Medrobotics is pleased the Flex® Robotic System has received this new recognition for its unique capabilities,” said Samuel Straface, Ph.D., President and CEO of Medrobotics. “Our products overcome the limits of traditional line-of-sight surgical technologies. Surgeons are now able to access difficult to reach anatomy through a single, small entry point and treat patients who might otherwise have required an open surgical procedure.”

Medrobotics’ Flex® Robotic System was designed to provide an affordable, easy-to-use robot-assisted surgical platform for hospitals and surgeons seeking to provide minimally-invasive treatment options to the broadest number of patients. Minimally invasive surgery has demonstrated advantages for patients and providers, such as shorter hospital stays and faster recovery times.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.